BioCentury | Aug 2, 2010
Product Development

Arcion's improved (noci)reception

...but not getting sufficient pain relief." The initial clinical work with ARC-4558 was conducted by Curatek Pharmaceuticals L.P....
...2000. The compound did not meet the primary endpoint of pain relief from baseline and Curatek...
...using the same capsaicin screening test. COMPANIES AND INSTITUTIONS Arcion Therapeutics Inc. , Baltimore, Md. Curatek Pharmaceuticals L.P....
BioCentury | May 22, 2000
Company News

Curatek Pharmaceuticals LP management update

Curatek Pharmaceuticals LP , Buffalo Grove, Ill. Business: Neurological Hired: James Juul as VP of marketing, sales and business development, formerly national sales manager, Women's Health Group at 3M Pharmaceuticals Inc. WIR Staff Neurology...
BioCentury | Mar 13, 2000
Clinical News

Topical clonidine gel: Began Phase III testing

...agonist Target: Alpha adrenergic receptors Description: Alpha-agonist hypotensive agent Indication: Treat peripheral neuropathic pain Status: Curatek...
BioCentury | Mar 7, 2000
Clinical News

Curatek starts Phase III

Curatek (Buffalo Grove, Ill.) began a 600-patient U.S. Phase III trial of its topical clonidine analgesic gel to treat peripheral neuropathic pain. BC Staff...
Items per page:
1 - 4 of 4
BioCentury | Aug 2, 2010
Product Development

Arcion's improved (noci)reception

...but not getting sufficient pain relief." The initial clinical work with ARC-4558 was conducted by Curatek Pharmaceuticals L.P....
...2000. The compound did not meet the primary endpoint of pain relief from baseline and Curatek...
...using the same capsaicin screening test. COMPANIES AND INSTITUTIONS Arcion Therapeutics Inc. , Baltimore, Md. Curatek Pharmaceuticals L.P....
BioCentury | May 22, 2000
Company News

Curatek Pharmaceuticals LP management update

Curatek Pharmaceuticals LP , Buffalo Grove, Ill. Business: Neurological Hired: James Juul as VP of marketing, sales and business development, formerly national sales manager, Women's Health Group at 3M Pharmaceuticals Inc. WIR Staff Neurology...
BioCentury | Mar 13, 2000
Clinical News

Topical clonidine gel: Began Phase III testing

...agonist Target: Alpha adrenergic receptors Description: Alpha-agonist hypotensive agent Indication: Treat peripheral neuropathic pain Status: Curatek...
BioCentury | Mar 7, 2000
Clinical News

Curatek starts Phase III

Curatek (Buffalo Grove, Ill.) began a 600-patient U.S. Phase III trial of its topical clonidine analgesic gel to treat peripheral neuropathic pain. BC Staff...
Items per page:
1 - 4 of 4